Related Experiment Video
Updated: Jun 19, 2025

Measuring Lactase Enzymatic Activity in the Teaching Lab
Published on: August 6, 2018
The journey toward disease modification in cow milk protein allergy
Rita Nocerino1,2,3, Laura Carucci1,2, Serena Coppola1,2
1Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
Insights
Cow milk protein allergy (CMPA) is a growing global health concern in children, impacting quality of life and healthcare costs. This review explores advancements in disease-modifying strategies for pediatric CMPA.
Area of Science:
- Pediatric Allergy and Immunology
- Gastroenterology
- Clinical Nutrition
Background:
- Cow milk protein allergy (CMPA) is a prevalent food allergy in children globally.
- Increasing prevalence, persistence, and severity negatively impact patient quality of life and management costs.
- Early-life CMPA can initiate the
Purpose of the Study:
- To review recent advancements in disease-modifying therapeutic options for pediatric CMPA.
- To highlight strategies that can alter the natural course of CMPA and prevent the allergic march.
Main Methods:
- Comprehensive literature review of recent studies on CMPA.
- Analysis of research on novel therapeutic approaches and disease modification strategies.
- Synthesis of findings related to the management and prevention of allergic comorbidities.
Main Results:
- Emerging therapeutic strategies show promise in modulating the disease course of CMPA.
- Understanding the
Conclusions:
- Disease modification offers a promising avenue for managing pediatric CMPA and mitigating the allergic march.
- Further research into these novel approaches is crucial for improving outcomes for affected children and families.
Abstract:
Cow milk protein allergy (CMPA) is one of the most common food allergies in the pediatric age worldwide. Prevalence, persistence, and severity of this condition are on the rise, with a negative impact on the health-related quality of life of the patients and families and on the costs related to its management. Another relevant issue is that CMPA in early life may be the first stage of the "allergic march," leading to the occurrence of other atopic manifestations later in life, especially asthma, atopic eczema, urticaria, and rhinoconjunctivitis. Thus, "disease modification" options that are able to modulate the disease course of pediatric patients affected by CMPA would be very welcomed by affected families and healthcare systems. In this review, we report the most relevant progress on this topic.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Allergic Drug Reactions
Allergic Reactions
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Cross-reactivity

